These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 29605385)

  • 21. Major decrease in the volume of the entorhinal cortex in patients with Alzheimer's disease carrying the apolipoprotein E epsilon4 allele.
    Juottonen K; Lehtovirta M; Helisalmi S; Riekkinen PJ; Soininen H
    J Neurol Neurosurg Psychiatry; 1998 Sep; 65(3):322-7. PubMed ID: 9728943
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Higher prevalence of cerebral white matter hyperintensities in homozygous APOE-ɛ4 allele carriers aged 45-75: Results from the ALFA study.
    Rojas S; Brugulat-Serrat A; Bargalló N; Minguillón C; Tucholka A; Falcon C; Carvalho A; Morán S; Esteller M; Gramunt N; Fauria K; Camí J; Molinuevo JL; Gispert JD
    J Cereb Blood Flow Metab; 2018 Feb; 38(2):250-261. PubMed ID: 28492093
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Single photon emission computed tomography and apolipoprotein E in Alzheimer's disease: impact of the epsilon4 allele on regional cerebral blood flow.
    Høgh P; Knudsen GM; Kjaer KH; Jørgensen OS; Paulson OB; Waldemar G
    J Geriatr Psychiatry Neurol; 2001; 14(1):42-51. PubMed ID: 11281316
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of Apolipoprotein E4 Polymorphism on the Gray Matter Volume and the White Matter Integrity in Subjective Memory Impairment without White Matter Hyperintensities: Voxel-Based Morphometry and Tract-Based Spatial Statistics Study under 3-Tesla MRI.
    Lee YM; Ha JK; Park JM; Lee BD; Moon E; Chung YI; Kim JH; Kim HJ; Mun CW; Kim TH; Kim YH
    J Neuroimaging; 2016; 26(1):144-9. PubMed ID: 25678236
    [TBL] [Abstract][Full Text] [Related]  

  • 25. APOE-epsilon4 and aging of medial temporal lobe gray matter in healthy adults older than 50 years.
    Taylor JL; Scanlon BK; Farrell M; Hernandez B; Adamson MM; Ashford JW; Noda A; Murphy GM; Weiner MW
    Neurobiol Aging; 2014 Nov; 35(11):2479-2485. PubMed ID: 24929969
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association between insomnia and cognitive performance, gray matter volume, and white matter microstructure in cognitively unimpaired adults.
    Grau-Rivera O; Operto G; Falcón C; Sánchez-Benavides G; Cacciaglia R; Brugulat-Serrat A; Gramunt N; Salvadó G; Suárez-Calvet M; Minguillon C; Iranzo Á; Gispert JD; Molinuevo JL;
    Alzheimers Res Ther; 2020 Jan; 12(1):4. PubMed ID: 31907066
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Probing the link between the APOE-ε4 allele and whole-brain gray matter using deep learning.
    Abrol A; Hajjar I; Calhoun V
    Annu Int Conf IEEE Eng Med Biol Soc; 2022 Jul; 2022():3506-3509. PubMed ID: 36086465
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mapping the effect of APOE epsilon4 on gray matter loss in Alzheimer's disease in vivo.
    Pievani M; Rasser PE; Galluzzi S; Benussi L; Ghidoni R; Sabattoli F; Bonetti M; Binetti G; Thompson PM; Frisoni GB
    Neuroimage; 2009 May; 45(4):1090-8. PubMed ID: 19349226
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Disrupted white matter structural networks in healthy older adult APOE ε4 carriers - An international multicenter DTI study.
    Cavedo E; Lista S; Rojkova K; Chiesa PA; Houot M; Brueggen K; Blautzik J; Bokde ALW; Dubois B; Barkhof F; Pouwels PJW; Teipel S; Hampel H;
    Neuroscience; 2017 Aug; 357():119-133. PubMed ID: 28596117
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protective effect of APOE epsilon 2 on intrinsic functional connectivity of the entorhinal cortex is associated with better episodic memory in elderly individuals with risk factors for Alzheimer's disease.
    Chen J; Shu H; Wang Z; Liu D; Shi Y; Xu L; Zhang Z
    Oncotarget; 2016 Sep; 7(37):58789-58801. PubMed ID: 27542235
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased brain activation during working memory in cognitively intact adults with the APOE epsilon4 allele.
    Wishart HA; Saykin AJ; Rabin LA; Santulli RB; Flashman LA; Guerin SJ; Mamourian AC; Belloni DR; Rhodes CH; McAllister TW
    Am J Psychiatry; 2006 Sep; 163(9):1603-10. PubMed ID: 16946187
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recognition memory is associated with altered resting-state functional connectivity in people at genetic risk for Alzheimer's disease.
    Matura S; Prvulovic D; Butz M; Hartmann D; Sepanski B; Linnemann K; Oertel-Knöchel V; Karakaya T; Fußer F; Pantel J; van de Ven V
    Eur J Neurosci; 2014 Oct; 40(7):3128-35. PubMed ID: 24989884
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gray matter network associated with risk for Alzheimer's disease in young to middle-aged adults.
    Alexander GE; Bergfield KL; Chen K; Reiman EM; Hanson KD; Lin L; Bandy D; Caselli RJ; Moeller JR
    Neurobiol Aging; 2012 Dec; 33(12):2723-32. PubMed ID: 22405043
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Apolipoprotein E homozygous ε4 allele status: Effects on cortical structure and white matter integrity in a young to mid-age sample.
    Goltermann J; Repple J; Redlich R; Dohm K; Flint C; Grotegerd D; Waltemate L; Lemke H; Fingas SM; Meinert S; Enneking V; Hahn T; Bauer J; Schmitt S; Meller T; Stein F; Brosch K; Steinsträter O; Jansen A; Krug A; Nenadić I; Baune BT; Rietschel M; Witt S; Forstner AJ; Nöthen M; Johnen A; Alferink J; Kircher T; Dannlowski U; Opel N
    Eur Neuropsychopharmacol; 2021 May; 46():93-104. PubMed ID: 33648793
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Apolipoprotein E genotype modulates effects of vitamin B12 and homocysteine on grey matter volume in Alzheimer's disease.
    Lee YM; Ha JK; Park JM; Lee BD; Moon E; Chung YI; Kim JH; Kim HJ; Mun CW; Kim TH; Kim YH
    Psychogeriatrics; 2016 Jan; 16(1):3-11. PubMed ID: 25919635
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synergistic effect of apolipoprotein E epsilon4 and butyrylcholinesterase K-variant on progression from mild cognitive impairment to Alzheimer's disease.
    Lane R; Feldman HH; Meyer J; He Y; Ferris SH; Nordberg A; Darreh-Shori T; Soininen H; Pirttilä T; Farlow MR; Sfikas N; Ballard C; Greig NH
    Pharmacogenet Genomics; 2008 Apr; 18(4):289-98. PubMed ID: 18334913
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlations between FDG PET glucose uptake-MRI gray matter volume scores and apolipoprotein E ε4 gene dose in cognitively normal adults: a cross-validation study using voxel-based multi-modal partial least squares.
    Chen K; Ayutyanont N; Langbaum JB; Fleisher AS; Reschke C; Lee W; Liu X; Alexander GE; Bandy D; Caselli RJ; Reiman EM
    Neuroimage; 2012 May; 60(4):2316-22. PubMed ID: 22348880
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nonlinear interaction between APOE ε4 allele load and age in the hippocampal surface of cognitively intact individuals.
    Martí-Juan G; Sanroma-Guell G; Cacciaglia R; Falcon C; Operto G; Molinuevo JL; González Ballester MÁ; Gispert JD; Piella G; ;
    Hum Brain Mapp; 2021 Jan; 42(1):47-64. PubMed ID: 33017488
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Patterns of cortical thickness according to APOE genotype in Alzheimer's disease.
    Gutiérrez-Galve L; Lehmann M; Hobbs NZ; Clarkson MJ; Ridgway GR; Crutch S; Ourselin S; Schott JM; Fox NC; Barnes J
    Dement Geriatr Cogn Disord; 2009; 28(5):476-85. PubMed ID: 19940480
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Altered PET functional brain responses in cognitively intact elderly persons at risk for Alzheimer disease (carriers of the epsilon4 allele).
    Scarmeas N; Habeck C; Anderson KE; Hilton J; Devanand DP; Pelton GH; Tabert MH; Flynn J; Park A; Ciappa A; Tycko B; Stern Y
    Am J Geriatr Psychiatry; 2004; 12(6):596-605. PubMed ID: 15545327
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.